BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24866501)

  • 1. A pharmacological paradox: may a neutral antagonist shift an agonist concentration-response curve to the left?
    Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):601-3. PubMed ID: 24866501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus.
    Jergas B; Schulte K; Bindila L; Lutz B; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):621-8. PubMed ID: 24853577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.
    Kangas BD; Delatte MS; Vemuri VK; Thakur GA; Nikas SP; Subramanian KV; Shukla VG; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2013 Mar; 344(3):561-7. PubMed ID: 23287700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
    Tai S; Nikas SP; Shukla VG; Vemuri K; Makriyannis A; Järbe TU
    Psychopharmacology (Berl); 2015 Aug; 232(15):2751-61. PubMed ID: 25772338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice.
    Wiley JL; Marusich JA; Zhang Y; Fulp A; Maitra R; Thomas BF; Mahadevan A
    Eur J Pharmacol; 2012 Nov; 695(1-3):62-70. PubMed ID: 22975289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.
    Wiskerke J; Stoop N; Schetters D; Schoffelmeer AN; Pattij T
    PLoS One; 2011; 6(10):e25856. PubMed ID: 22016780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
    Klumpers LE; Fridberg M; de Kam ML; Little PB; Jensen NO; Kleinloog HD; Elling CE; van Gerven JM
    Br J Clin Pharmacol; 2013 Dec; 76(6):846-57. PubMed ID: 23601084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors.
    Baur R; Gertsch J; Sigel E
    Br J Pharmacol; 2012 Apr; 165(8):2479-84. PubMed ID: 21470203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
    Makwana R; Molleman A; Parsons ME
    Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
    Gamage TF; Ignatowska-Jankowska BM; Wiley JL; Abdelrahman M; Trembleau L; Greig IR; Thakur GA; Tichkule R; Poklis J; Ross RA; Pertwee RG; Lichtman AH
    Behav Pharmacol; 2014 Apr; 25(2):182-5. PubMed ID: 24603340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
    Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.
    Wiley JL; Breivogel CS; Mahadevan A; Pertwee RG; Cascio MG; Bolognini D; Huffman JW; Walentiny DM; Vann RE; Razdan RK; Martin BR
    Eur J Pharmacol; 2011 Jan; 651(1-3):96-105. PubMed ID: 21114999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats.
    Järbe TU; DiPatrizio NV; Lu D; Makriyannis A
    Behav Pharmacol; 2004 Nov; 15(7):517-21. PubMed ID: 15472574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
    Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
    Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'.
    Gardner A; Mallet PE
    Eur J Pharmacol; 2006 Jan; 530(1-2):103-6. PubMed ID: 16380113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
    Gamble-George JC; Conger JR; Hartley ND; Gupta P; Sumislawski JJ; Patel S
    Psychopharmacology (Berl); 2013 Aug; 228(3):401-9. PubMed ID: 23483200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.